An FDA panel has voted against recommending approval of a booster COVID-19 shot for the general population – disappointing some public health officials.
L’expertise universitaire, l’exigence journalistique
Articles sur Immunology
Affichage de 41 à 60 de 100 articles
‘Breakthrough’ infections can happen because of waning immunity or high viral doses. But our vaccines are still excellent at preventing severe disease and death.
A COVID-19 vaccine does not cause infertility – but it can protect you from the dangerous complications of contracting the virus.
Recovering from COVID and then getting vaccinated, known as hybrid immunity, is more potent than being infected or vaccinated alone.
New DNA evidence shows humans may have been battling coronaviruses for longer than recorded history.
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it’s better for individuals to mix what’s available.
Vaccination is likely to substantially reduce virus transmission by reducing the pool of people who become infected, and reducing virus levels in people who do get infected.
Scientists around the world are trying to come up with universal coronavirus vaccines to combat the emergence of variants. But what are these vaccines and are they even possible?
Children in the study seemed to display a very strong “innate” immune response.
Maintaining antibodies in the blood requires creating certain long-lasting immune cells – but this doesn’t always happen.
While the whole world is obsessed by the COVID-19 pandemic, another equally deadly threat is going unnoticed: antibiotic resistance.
Long-term protection will depend on the ‘memory response’ developed by our immune systems – and the initial signs are promising.
Sterilising immunity means that the immune system is able to completely prevent a virus from replicating in your body. Not all vaccines provide this.
Fauci turns 80 this Dec. 24 – and he’s been on the national stage for decades. Here’s more about his work before COVID-19 and why he was perfectly poised to help the US respond to the pandemic.
Several new studies show our immune responses to the virus can last at least eight or nine months, and probably longer.
A new study is the first to identify sex differences in inflammation and immune cell activation in response to SARS-CoV-2 infection, which causes COVID-19.
Our first exposure to a pathogen, either naturally or via vaccination, can affect how our immune system responds in the future to the same or similar pathogens.
A group of 28 vaccine researchers said we might have a vaccine by late-2021, though it could take until well into 2022.
Older coronavirus patients face grimmer outlooks. A virologist explains the aging-related changes in how immune systems work that are to blame.
Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.
Les contributeurs les plus fréquents
-
Research Fellow, Institute for Molecular Bioscience, The University of Queensland
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Program Director, Infectious Diseases and Immunology, Menzies Health Institute, Griffith University
-
Instructor of Human Immunology, Emory University
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Associate Professor of Viral Immunology, Department of Pathobiology, University of Guelph
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Immunology, RMIT University
-
Laboratory Head, Walter and Eliza Hall Institute
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Associate Professor of Microbiology, Immunology & Pathology, Colorado State University
-
Senior Lecturer; MD, Victoria University
-
Professor of Immunology and Associate Dean, Research and Graduate Studies, University of Guelph
-
Ph.D. Candidate in Chemical & Physical Biology, Vanderbilt Vaccine Center, Vanderbilt University
-
Ph.D. Student in Microbiology and Immunology, Vanderbilt Vaccine Center, Vanderbilt University
